Dr. Schuchter on the Progression of Melanoma Care

Lynn M. Schuchter, MD, division chief of hematology-oncology at the Abramson Cancer Center at the University of Pennsylvania in Philadelphia describes how treatment in melanoma has advanced over the past 25 years, starting with the first drugs approved for the disease and advancing into the modern era.